Date post: | 14-Jan-2017 |
Category: |
Government & Nonprofit |
Upload: | peter-mountford |
View: | 33 times |
Download: | 0 times |
Academic Social ResponsibilityNew leadership and new resources to help address global
challenges
Peter Mountford PhD. World Health Summit, Berlin – October 2012
Massachusetts
Big picture through to definitive actions
Why academic leadership in addressing global challenges?
What resources to contribute?
Where and how to contribute?
Agenda
5
History has shown…….
Success will require not only leadership and resources, but also time
Religion Governments IndividualsIndustry
All have tried and continue to do great work, but……….
So far ……….
- The “gap” continues to grow, and
- The challenges are increasing (global warming, ageing population, disaster fatigue)
Success will require not only leadership and resources, but also time
6
Institutional leaders have conflicting interests, and
The efforts of individuals are simply not enough.
Academic Social Responsibility shall harness interdisciplinary expertise and scientific
discovery to help deliver lasting change.
With such great leaders and so many resources, why is it so?
Religion Governments IndividualsIndustry
History has shown…….
ASR - complimenting the efforts of government, civil society and business
Academic Social Responsibility
Cutting edge, collaborative, multi-disciplinary, publicly funded, independent and global………“The Commonwealth of Science”
Unable and/or unwilling?
Corporate socialresponsibility
AusAID, USAID
Gates FoundationNGOs
Slide presented by D. Wachtler and D. Waughray - World Economic Forum on Slim City/Environment
9
The opportunity- Science and innovation are major drivers of modern economic prosperity
- Governments are investing in R&D to secure downstream benefit in the “knowledge economy”
- Philanthropic and medical research charities are investing to find cures / protect the environment
- Scientists are investing to find cleaner energy, recycle waste, and improve food/water supply and health
- Great wealth and many other benefits will flow from these investments
Innovation
Value adding development
Realization of benefit
Basic research discoveries
Value / benefit
Time
Government investment
Academic Social Responsibility
Academic Social Responsibility
*Entrepreneurial Impact: The Role of MIT. Edward Roberts and Charles Eesley. MIT Sloan School of Management, February 2009
The opportunity - Massachusetts Institute of Technology as one potential example
Roberts and Eesley* estimated that at the time of their survey (2003) that there were some 25,800 operational companies that had been founded or co-founded by MIT alumni. These companies employed some 3.3 million people and generated sales close to $2 trillion per year. Had MIT alumni universally adopted an ASR commitment to donate 0.1% of sales some 40 years ago, ASR contributions from MIT alumni would be delivering $2 billion to public causes every year.
11
The challenge- Beneficial entitlement is determined by competitive market forces
- Complex, costly and long development processes favor the biggest and most competitive
- Smaller nations struggle to realize fair value for part contribution in the global market
- Emerging nations face even greater challenges competing against established high technology leaders
- Sadly, competition, long development times and self-interest distance wealth and responsibility from moral obligations and global needs
Value adding development
Realization of benefit
Basic research discoveries
Super tech hubs
Advanced nations
Value / benefit
Time
3rd world
Emerging nations
Innovation
Government investment
Academic Social Responsibility
The solution?
- Collaborating academic scientists include a licensing obligation that requires downstream developers of their technology to provide appropriate access for unmet global needs.- For example, scientists working on a more drought resistant form of wheat may require those who develop their technology to make the resulting seed available to poorer nations at a discounted price.
12
Super tech hubs
Innovation
3rd world
Value / benefit
Time
ASR approach starts here
So as to better protect beneficial entitlement here
Advanced nations
Emerging nations
Academic Social Responsibility
and here
A working example
Academic Social Responsibility
Value / benefit
TimeInnovation
13
$3 billion of state investment for Regenerative Medicine
(f) A Grantee, Collaborator, or an Exclusive Licensee that is commercializing the Drug must provide a Drug, that resulted in whole or in part from CIRM-Funded Research, at a price as provided in the California Discount Prescription Drug Program (commencing with California Health and Safety Code section 130500) (or a successor statewide prescription drug discount program) to eligible Californians under said Program.
(g) A Grantee, Collaborator or its Exclusive Licensee that is commercializing the Drug must sell a Drug, that resulted in whole or in part from CIRM-Funded Research, and which is purchased in California with Public Funds (as defined in Title 17, California Code of Regulations, section 100601, subdivision (q)) at any benchmark price described in the California Discount Prescription Drug Program or a successor statewide prescription drug discount program.
Californianpatients
Californianindustry
Requirementsimposed here
To ensure future beneficial entitlement here
“Proposition 71” requires that all recipients of state funding guarantee cheap future access to beneficial outcomes for all Californians
14
The value drivers- Greater wealth/benefit will be created by improving innovation efficiency
- Efficiency shall be improved via enhanced collaboration under forward-looking frameworks
- Collaborative endeavor will be adopted because ASR cooperative frameworks shall
- Build on common motivations and diverse sources of complimentary investment,
- Improve competitiveness and value of member contributions, and
- Ensure fair distribution of benefit according to the value of individual member
contributions and moral obligations.
Value adding development
Realization of benefit
Basic research discoveries
Super tech hubsAdvanced nations
3rd world
Value / benefit
Time
Emerging nations
Innovation
Government investment
Academic Social Responsibility
Cooperative framework/s
15
Academic Social Responsibility
Complimenting the philanthropic efforts of government, industry and civil society
A new opportunity for independent leadership and global change
- Directly linking those academic experts who monitor and investigate major global issues with the independent resources needed for lasting change.
Academic Social Responsibility
1. ASR uptake in a high profile international pilot program
Recruit high profile supporters from multiple sectors of society for a global market launch
Marketing strategy to ensure global buy-in
Target a high impact sector witha reasonably probability for
successScientific recruitment of a first Innovation Cooperative
17
ASR development strategy – 2 parallel initiatives
2. Global launch supported by high profile figures
ASR pilot program strategy
Value / benefit
*Global challenges
Incentives promote collaboration and increased levels of benefit
ASR delivers socialchange
RIKEN UCSF
Uni. Nice Australia
Sth KoreaGCC
WCSCR 2) Recruit a first high profile international cooperative to credibly demonstrate the ASR concept on the global stage
1) Australian academic leaders design plausible ASR commitments and develop launch/marketing strategy
ASR cooperative framework/s
Time
Confirmed “in-principle” supporters wishing to explore next stage
Stem cell scientists / senior academics- Professor Doug Hilton (Director, WEHI)- Dr. Keith Mclean (Theme Leader, CSIRO)- Professor Martin Pera (Director, Stem Cells Australia)
- Professor Jonathon West (Director, Australian Innovation Research Centre)- Professor Peter Rathjen (Vice Chancellor, University of Tasmania)- Professor Ron Johnson (Chair, NETS Expert Panel)- Professor Simon Longstaff (Director, St. James Ethics Centre)
Social innovation- Dr. Andrew MacLeod (CEO, Committee for Melbourne, UN Corporate Social
Responsibility)- Dr. Alan Dormer (Theme Leader, CSIRO / Government and Commercial
Services)
Other- Professor Ian Chubb (Chief Scientist, Federal Government)- Professor David de Kretser (Monash Institute and recently retired Governor of
Victoria)- Dr Susan Hawes (Dept. Innovation, Federal Government)- Dr. Anna Lavelle (CEO, AusBiotech)- Mr. Chris Lovell (MD, Holding Redlich Lawyers)- Dr Mark Nelson (MD, Caledonia Investments)- Professor Brian Heap (The Royal Society, London)
What is the next stage of the process?
Stage 1Concept development and testing
Stage 2Formalize R&D Program & Partners
Stage 3Framework development
Stage 4Pilot program road test / recruitment
Stage 5Global launch of ASR concept
Stage 2 – Think tank- Bringing key partners together for a detailed analysis of the challenges, options
and feasibility- Full mapping of objectives, strategy, R&D project requirements, preferred partner
organizations and resourcing needs/opportunities
Prospectus prepared to attract investment.